Enter Note Done

Session


D. Gerding: C. Consultant; Self; MGB BioPharma, Medpace. J. Scientific Advisor (Review Panel or Advisory Committee); Self; Merck, Rebiotix, Actelion. O. Do you intend to include human data in your presentation?; Self; Yes. P. Other; Self; Patents and technology for Non-toxigenic C difficile.

Dale Gerding; Loyola Univ. Chicago Stritch Sch. of Med., Chicago, IL
Track
Antimicrobial Agents and Resistance
Subtrack
AAR08 - New Antimicrobial Agents
AAR09 - Pharmacological Studies of Investigational Agents Pre-NDA
Course Level
Intermediate
Session Type
Symposium
Curated Itineraries
New Agents in Pipeline